Gainers
- Bolt Biotherapeutics (NASDAQ:BOLT) shares moved upwards by 58.8% to $6.65 during Friday's regular session. The market value of their outstanding shares is at $7.9 million.
- Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 34.26% to $0.44. The market value of their outstanding shares is at $63.6 million.
- Estrella Immunopharma (NASDAQ:ESLA) stock moved upwards by 27.26% to $0.92. The company's market cap stands at $23.9 million.
- Streamex (NASDAQ:STEX) stock increased by 27.14% to $0.45. The market value of their outstanding shares is at $42.9 million.
- Nautilus Biotechnology (NASDAQ:NAUT) shares rose 20.57% to $3.13. The company's market cap stands at $344.8 million.
- NeOnc Technologies Hldgs (NASDAQ:NTHI) shares rose 17.96% to $3.48. The company's market cap stands at $83.5 million.
Losers
- Aardvark Therapeutics (NASDAQ:AARD) stock fell 56.5% to $1.72 during Friday's regular session. The market value of their outstanding shares is at $96.5 million.
- Lunai Bioworks (NASDAQ:LNAI) stock fell 50.43% to $0.23. The market value of their outstanding shares is at $2.3 million.
- Lakewood-Amedex (NASDAQ:LABT) stock fell 39.9% to $0.29. The market value of their outstanding shares is at $1.1 million.
- Pomdoctor (NASDAQ:POM) shares decreased by 34.98% to $1.32. The company's market cap stands at $8.3 million.
- Macrogenics (NASDAQ:MGNX) stock decreased by 33.65% to $2.41. The market value of their outstanding shares is at $228.6 million.
- Alaunos Therapeutics (NASDAQ:TCRT) stock decreased by 25.5% to $2.27. The market value of their outstanding shares is at $7.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.




